Stephen Rhind

Stephen Rhind is a highly experienced professional in the field of commercialization, currently serving as Commercialisation Manager at both the John Innes Centre since July 2023 and the Quadram Institute since July 2021. With a strong consulting background, Stephen has also been a Commercial Consultant for Kagulex Consulting Limited since October 2012. Previous key roles include Non Executive Director at Quell Therapeutics Limited from April 2019 to January 2021, Deputy Director at King's Commercialisation Institute from July 2018 to November 2020, and Head of Business Development at Silence Therapeutics plc from July 2015 to July 2017. Stephen's early career includes significant consulting positions and a senior leadership role as SVP of Corporate Development at S*BIO Pte Ltd from 2005 to July 2011. Educational qualifications include a Ph.D in Biochemistry from the University of Cambridge and a BSc in Biochemistry from The University of Manchester.